SPDL1 and diffuse large B-cell lymphoma: Although high level of plasma sPD-L1 is associated with poor prognosis in DLBCL patients 17, there are no reports on the effect of plasma sPD-L1 combined with plasma STAT3 on the prognosis in DLBCL patients.